OpenAI will not go public in 2026, CEO Sam Altman says, putting one of the technology industry’s most anticipated listings on hold as concerns about increasingly capable artificial intelligence move closer to the center of frontier-lab strategy.
Reuters reported that Altman called the current environment an “ill-advised moment to go public” because of what is happening around AI safety, adding that OpenAI does not feel pressure to proceed with a listing this year.
Asked directly about an IPO in 2026, Altman ruled it out while saying the company still has substantial work ahead on safety, alignment and coordination between governments and the AI industry.
Altman calls extinction risk unacceptable
The IPO comments came alongside one of Altman’s clearest acknowledgements of catastrophic AI risk.
Reuters reported that Altman said even a 10% chance of AI causing human extinction would be “unacceptable”, arguing that AI developers and governments need to work together as models become increasingly powerful.
The warning follows a period of growing anxiety inside the AI industry over whether increasingly autonomous systems can be reliably controlled.
Ground News framed the broader development as an unusual convergence among Altman, Anthropic CEO Dario Amodei and Elon Musk, with the three prominent AI figures warning that AI development is moving too quickly.
Amodei has called for AI companies to slow the rate at which they improve their most advanced models, while Altman has publicly supported the idea of giving independent evaluators deeper access to inspect safety practices. Musk has also backed Amodei’s call for a slower pace.
OpenAI’s IPO now collides with its safety obligations
The decision is significant because OpenAI has already taken steps toward the public markets.
The company confidentially filed IPO paperwork earlier in 2026, and a listing has been viewed as a potential source of capital for a business facing enormous computing and infrastructure requirements. Altman’s latest comments make clear, however, that a 2026 OpenAI IPO is now off the table.
That creates an unusual tension for one of the world’s most valuable technology companies. Public markets typically reward growth, product releases and expanding revenue. Frontier AI laboratories are simultaneously arguing that the technology may sometimes need to advance more slowly when safety systems cannot keep pace.
Safety is becoming a business constraint
For founders and investors, OpenAI’s decision shows that AI safety is no longer only a research or regulatory issue.
It is beginning to influence capital-market timing, product development and the way frontier labs describe their responsibilities.
Altman has also suggested that leading AI companies could work toward a broader industry agreement on safety, while Reuters reported that he sees a need for greater coordination between AI companies and governments.
That leaves OpenAI balancing two competing imperatives: raising the enormous capital required to remain at the frontier while convincing governments, researchers and eventually public investors that its systems can be scaled responsibly.
The bigger signal is that AI safety is starting to affect not only how models are built, but when the companies building them believe they are ready for Wall Street.
